RwHealth is a healthtech specialist which provides predictive analytics and insights through an innovative platform to customers across the healthcare and pharmaceutical sectors. Clients can use these analytics and deep insights to optimise care pathways and improve patient outcomes, whilst enabling effective resource and capacity planning.
RwHealth‘s software solution utilises artificial intelligence (AI) and machine learning (ML) to ingest and unify data from disparate sources including electronic medical record systems, clinical trial design systems and patient safety records. This comprehensive linking of information is providing clinicians with an advanced layer of insight into a patient’s journey through the healthcare system and the challenges that arise through patient flow. This enables management to adjust planning and focus accordingly on better diagnosing diseases.
RwHealth is at the forefront of the drive to use Real World Evidence and predictive analytics more effectively in the healthcare and pharma sectors. Ultimately, this will enable better patient outcomes and will be more vital than ever in the post pandemic era. The company has seen significant commercial growth through its blue chip customer base which includes NHS Trusts and large pharma companies and is now poised to scale up internationally. We are delighted to be able to support the company’s next phase of growth through this investment via a number of our funds and co-investment partners.
Alexander Sleigh, Investment Director at Maven
Subscribe for email updates
